<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="associated with resistance, rapidly detecting multidrug-resistant TB strains resistant to" exact="rifampin" post="and isoniazid, allowing appropriate therapies and curbing transmission of"/>
 <result pre="the viral entry to the cell [180, 228, 229]. Chloroquine," exact="hydroxychloroquine" post="and baricitinib mechanisms of action are not fully understood;"/>
 <result pre="inhibit the proteolysis. Lopinavir/ritonavir inhibits specifically the proteinase 3CLpro [231]." exact="Ribavirin" post="and favipiravir both have wide antiviral activity and have"/>
 <result pre="TB/HIV co-infected patients, lopinavir/ritonavir is not recommended in combination with" exact="rifampicin" post="due to cytochrome P450 (CYP) induction. Superboosting of lopinavir/ritonavir"/>
 <result pre="to cytochrome P450 (CYP) induction. Superboosting of lopinavir/ritonavir by additional" exact="ritonavir" post="in children on rifampicin-based TB treatment could be attempted"/>
 <result pre="attempted as comparable drug exposure was achieved in situations without" exact="rifampicin" post="[166]. Alternatively, rifabutin at a dose of 150â€…mg once"/>
 <result pre="drug exposure was achieved in situations without rifampicin [166]. Alternatively," exact="rifabutin" post="at a dose of 150â€…mg once daily has been"/>
 <result pre="once daily has been used in combination with lopinavir/ritonavir [167]." exact="Chloroquine" post="phosphate and hydroxychloroquine Chloroquine and hydroxychloroquine are being evaluated"/>
 <result pre="been used in combination with lopinavir/ritonavir [167]. Chloroquine phosphate and" exact="hydroxychloroquine" post="Chloroquine and hydroxychloroquine are being evaluated in several clinical"/>
 <result pre="used in combination with lopinavir/ritonavir [167]. Chloroquine phosphate and hydroxychloroquine" exact="Chloroquine" post="and hydroxychloroquine are being evaluated in several clinical trials"/>
 <result pre="combination with lopinavir/ritonavir [167]. Chloroquine phosphate and hydroxychloroquine Chloroquine and" exact="hydroxychloroquine" post="are being evaluated in several clinical trials for therapy"/>
 <result pre="unknown [169, 170]. Both drugs have immunomodulatory properties [171, 172]." exact="Chloroquine" post="has been shown to reduce tumour necrosis factor-Î± production"/>
 <result pre="combining these drugs with TB drugs such as moxifloxacin, bedaquiline," exact="delamanid" post="and clofazimine due to the risk of increased QTc"/>
 <result pre="drugs with TB drugs such as moxifloxacin, bedaquiline, delamanid and" exact="clofazimine" post="due to the risk of increased QTc prolongation. An"/>
 <result pre="issued a warning on these two drugs [175]. In addition," exact="rifampicin" post="increases chloroquine CYP3A4- and CYP2D6-mediated metabolism to desethylchloroquine and"/>
 <result pre="warning on these two drugs [175]. In addition, rifampicin increases" exact="chloroquine" post="CYP3A4- and CYP2D6-mediated metabolism to desethylchloroquine and bisdesethylchloroquine [176]."/>
 <result pre="meropenem; AMI: amikacin; STR: streptomycin; ETO: ethionamide; PTO: prothionamide; PAS:" exact="p-aminosalicylic acid;" post="CYP: cytochrome P450; UGT: UDP glucuronosyltransferase. #: recommended based"/>
 <result pre="in the metabolism of baloxavir (minor extent) and umifenovir, and" exact="clofazimine" post="is a CYP3A4 inhibitor; Æ’: both drugs primarily undergo"/>
 <result pre="Janus kinase JAK1/JAK2 inhibitor baricitinib are being studied [177, 178]." exact="Azithromycin" post="may be of potential interest for its immunomodulatory effect"/>
 <result pre="drugs Antiviral candidates such as azvudine, baloxavir marboxil, favipiravir, remdesivir," exact="ribavirin" post="and umifenovir are being tested for COVID-19 (figure 2)"/>
 <result pre="virus: ice-cold acetone (90â€…s), ice-cold acetone/methanol mixture (40/60, 10â€…min), 70%" exact="ethanol" post="(10â€…min), 100% ethanol (5â€…min), paraformaldehyde (2â€…min) and glutaraldehyde (2â€…min)."/>
 <result pre="(90â€…s), ice-cold acetone/methanol mixture (40/60, 10â€…min), 70% ethanol (10â€…min), 100%" exact="ethanol" post="(5â€…min), paraformaldehyde (2â€…min) and glutaraldehyde (2â€…min). Commonly used brands"/>
 <result pre="that can be damaged by sodium hypochlorite, products based on" exact="ethanol" post="of at least 70% can be used [203]. The"/>
 <result pre="to 48â€…h on plastic surfaces [205], and 6â€…days in the" exact="dried" post="state [202]. The virus does not survive well after"/>
 <result pre="5 (13.5) 8 (21.6) 15 (40.5) 8 (21.6) 3.7Â±1.1 12." exact="Chloroquine" post="and hydroxychloroquine have potential to improve the treatment success"/>
 <result pre="8 (21.6) 15 (40.5) 8 (21.6) 3.7Â±1.1 12. Chloroquine and" exact="hydroxychloroquine" post="have potential to improve the treatment success rate of"/>
 <result pre="E32â€&quot;E42. doi:10.1016/S2352-3018(18)30293-5 167LanNT, ThuNT, Barrail-TranA, et al.Randomised pharmacokinetic trial of" exact="rifabutin" post="with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in"/>
 <result pre="in Vietnam. PLoS One2014; 9: e84866. doi:10.1371/journal.pone.008486624465443 168PrincipiN, EspositoSChloroquine or" exact="hydroxychloroquine" post="for prophylaxis of COVID-19. Lancet Infect Dis2020; in press"/>
 <result pre="in press [10.1016/S1473-3099(20)30296-6]. doi:10.1016/S1473-3099(20)30296-6 169ChenZ, HuJ, ZhangZ, et al.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
 <result pre="2020; preprint [10.1101/2020.03.22.20040758]. doi:10.1101/2020.03.22.20040758 170GautretP, LagierJC, ParolaP, et al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="Immunol2012; 42: 145â€&quot;153. doi:10.1007/s12016-010-8243-x21221847 173SavarinoA, BoelaertJR, CassoneA, et al.Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases?Lancet"/>
 <result pre="ValFFA, SampaioVS, et al.Effect of high vs low doses of" exact="chloroquine" post="diphosphate as adjunctive therapy for patients hospitalized with severe"/>
 <result pre="doi:10.1001/jamanetworkopen.2020.885732330277 175collab: Food and Drug AdministrationFDA cautions against use of" exact="hydroxychloroquine" post="or chloroquine for COVID-19 outside of the hospital setting"/>
 <result pre="Food and Drug AdministrationFDA cautions against use of hydroxychloroquine or" exact="chloroquine" post="for COVID-19 outside of the hospital setting or a"/>
 <result pre="Discov2020; 19: 149â€&quot;150. doi:10.1038/d41573-020-00016-032127666 182WangM, CaoR, ZhangL, et al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="drug combination features and better inhibition on drug-resistant strains than" exact="lamivudine" post="in vitro. PLoS One2014; 9: e105617. doi:10.1371/journal.pone.010561725144636 236AbrahamGM, MortonJB,"/>
 <result pre="April 1, 2020. 243PandieM, WiesnerL, McIlleronH, et al.Drugâ€&quot;drug interactions between" exact="bedaquiline" post="and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients"/>
 <result pre="et al.Drugâ€&quot;drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and" exact="nevirapine" post="in HIV-infected patients with drug-resistant TB. J Antimicrob Chemother2016;"/>
 <result pre="doi:10.1111/jphp.1201423488780 246LuZK, YuanJ, LiM, et al.Cardiac risks associated with antibiotics:" exact="azithromycin" post="and levofloxacin. Expert Opin Drug Saf2015; 14: 295â€&quot;303. doi:10.1517/14740338.2015.98921025494485"/>
 <result pre="295â€&quot;303. doi:10.1517/14740338.2015.98921025494485 247ChatreC, RoubilleF, VernhetH, et al.Cardiac complications attributed to" exact="chloroquine" post="and hydroxychloroquine: a systematic review of the literature. Drug"/>
 <result pre="doi:10.1007/s40264-018-0689-429858838 248KrzeminskiP, LesiakA, NarbuttJSeizures as a rare adverse effect of" exact="chloroquine" post="therapy in systemic lupus erythematosus patients: a case report"/>
 <result pre="Heart J2016; 37: 2768â€&quot;2801. doi:10.1093/eurheartj/ehw21127567406 252ShakilAO, Di BisceglieAM, HoofnagleJHSeizures during" exact="alpha" post="interferon therapy. J Hepatol1996; 24: 48â€&quot;51. doi:10.1016/S0168-8278(96)80185-18834024 253SharifianMR, KamandiS,"/>
</results>
